Prof. Dr. ID: 37856

Nicolaus-Martin Kröger

Head of Clinic

graph of relations

Publications

  1. 2012
  2. Allogene Stammzelltransplantation bei Myelofibrose

    Kröger, N. & Alchalby, H., 2012, Aktuelle Therapieoptionen bei der Myelofibrose. UNI-MED Verlag, p. 47-56 10 p.

    Research output: SCORING: Contribution to book/anthologySCORING: Contribution to collected editions/anthologiesResearchpeer-review

  3. Allogene Stammzelltransplantation zur Therapie der Osteomyelofibrose

    Kröger, N., 2012, Blutstammzelltransplantation - Bilanz des aktuellen Wissens. düsseldorf university press, p. 139-155 17 p.

    Research output: SCORING: Contribution to book/anthologySCORING: Contribution to collected editions/anthologiesResearchpeer-review

  4. Diagnostic performance of whole-body MRI for the detection of persistent or relapsing disease in multiple myeloma after stem cell transplantation.

    Bannas, P., Hentschel, H. B., Bley, T., Treszl, A., Zu Eulenburg, C. G., Derlin, T., Yamamura, J., Adam, G., Stübig, T., Kröger, N. & Weber, C., 2012, In: EUR RADIOL. 22, 9, p. 2007-2012 9.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  5. Donor lymphocyte infusions and second transplantation as salvage treatment for relapsed myelofibrosis after reduced-intensity allografting.

    Klyuchnikov, E., Holler, E., Bornhäuser, M., Kobbe, G., Nagler, A., Shimoni, A., Könecke, C., Wolschke, C., Bacher, U., Zander, A. R. & Kröger, N., 2012, In: BRIT J HAEMATOL. 159, 2, p. 172-181 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  6. European data on stem cell mobilization with plerixafor in non-Hodgkin's lymphoma, Hodgkin's lymphoma and multiple myeloma patients. A subgroup analysis of the European Consortium of stem cell mobilization.

    Hübel, K., Fresen, M. M., Apperley, J. F., Basak, G. W., Douglas, K. W., Gabriel, I. H., Geraldes, C., Jaksic, O., Koristek, Z., Kröger, N., Lanza, F., Lemoli, R. M., Mikala, G., Selleslag, D., Worel, N., Mohty, M. & Duarte, R. F., 2012, In: BONE MARROW TRANSPL. 47, 8, p. 1046-1050 8.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  7. Immunotherapy for multiple myeloma.

    Kröger, N., Mohty, M., Nagler, A. & Yi, Q., 2012, In: Clin Dev Immunol. 2012, p. 797165

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  8. Impact of the NK cell receptor LIR-1 (ILT-2/CD85j/LILRB1) on cytotoxicity against multiple myeloma.

    Heidenreich, S., Zu Eulenburg, C. G., Hildebrandt, Y., Stübig, T., Sierich, H., Badbaran, A., Eiermann, T., Binder, T. & Kröger, N., 2012, In: Clin Dev Immunol. 2012, p. 652130

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  9. Longitudinal analysis of tetanus- and influenza-specific IgG antibodies in myeloma patients.

    Kobold, S., Luetkens, T., Bartels, B. M., Cao, Y., Hildebrandt, Y., Sezer, O., Reinhard, H., Templin, J., Bartels, K., Lajmi, N., Haag, F., Bokemeyer, C., Kröger, N. & Atanackovic, D., 2012, In: Clin Dev Immunol. 2012, p. 134081

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  10. Plerixafor for autologous peripheral blood stem cell mobilization in patients previously treated with fludarabine or lenalidomide.

    Malard, F., Kröger, N., Gabriel, I. H., Hübel, K., Apperley, J. F., Basak, G. W., Douglas, K. W., Geraldes, C., Jaksic, O., Koristek, Z., Lanza, F., Lemoli, R., Mikala, G., Selleslag, D., Worel, N., Mohty, M. & Duarte, R. F., 2012, In: BIOL BLOOD MARROW TR. 18, 2, p. 314-317 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  11. Replacement of hematopoietic system by allogeneic stem cell transplantation in myelofibrosis patients induces rapid regression of bone marrow fibrosis.

    Kröger, N., Kvasnicka, M. & Thiele, J., 2012, In: Fibrogenesis Tissue Repair. 5 Suppl 1, p. 25

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  12. Risk models predicting survival after reduced-intensity transplantation for myelofibrosis.

    Alchalby, H., Yunus, D-R., Zabelina, T., Kobbe, G., Holler, E., Bornhäuser, M., Schwerdtfeger, R., Bethge, W., Kvasnicka, H. M., Büsche, G., Ayuketang Ayuk, F., Bacher, U., Zander, A. R. & Kröger, N., 2012, In: BRIT J HAEMATOL. 157, 1, p. 75-85 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  13. Role of interleukin 16 in multiple myeloma.

    Atanackovic, D., Hildebrandt, Y., Templin, J., Cao, Y., Keller, C., Panse, J., Meyer, S., Reinhard, H., Bartels, K., Lajmi, N., Sezer, O., Zander, A. R., Marx, A., Uhlig, R., Zustin, J., Bokemeyer, C. & Kröger, N., 2012, In: JNCI-J NATL CANCER I. 104, 13, p. 1005-1020 13.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  14. Similar incidences of TP53 deletions in extramedullary organ infiltrations, soft tissue and osteolyses of patients with multiple myeloma.

    Billecke, L., Murga-Penas, E-M., May, A. M., Engelhardt, M., Nagler, A., Leiba, M., Schiby, G., Kröger, N., Zustin, J., Marx, A., Matschke, J., Tiemann, M., Goekkurt, E., Bokemeyer, C. & Schilling, G., 2012, In: ANTICANCER RES. 32, 5, p. 2031-2034 5.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  15. Therapy-related myeloid neoplasms following treatment with radioiodine.

    Schroeder, T., Kuendgen, A., Kayser, S., Kröger, N., Braulke, F., Platzbecker, U., Klärner, V., Zohren, F., Haase, D., Stadler, M., Schlenk, R., Czibere, A. G., Bruns, I., Fenk, R., Gattermann, N., Haas, R., Kobbe, G. & Germing, U., 2012, In: HAEMATOLOGICA. 97, 2, p. 206-212 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  16. Treatment, risk factors, and outcome of adults with relapsed AML after reduced intensity conditioning for allogeneic stem cell transplantation.

    Schmid, C., Labopin, M., Nagler, A., Niederwieser, D., Castagna, L., Tabrizi, R., Stadler, M., Kuball, J., Cornelissen, J., Vorlicek, J., Socié, G., Falda, M., Vindeløv, L., Ljungman, P., Jackson, G., Kröger, N., Rank, A., Polge, E., Rocha, V., Mohty, M., Blood, A. L. W. P. O. T. E. G. F. & Transplantation, M., 2012, In: BLOOD. 119, 6, p. 1599-1606 6.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  17. 2011
  18. Purification of CD4+ T cells for adoptive immunotherapy after allogeneic hematopoietic stem cell transplantation

    Klyuchnikov, E., Sputtek, A., Slesarchuk, O., Lioznov, M., Stübig, T., Bacher, U., Amtsfeld, G., Merle, E., Reckhaus, M-L., Fehse, B., Wolschke, C., Adjalle, R., Ayuketang Ayuk, F., Zander, A. R. & Kröger, N., 01.03.2011, In: BIOL BLOOD MARROW TR. 17, 3, p. 374-383 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  19. Allogeneic stem cell transplantation for myelodysplastic syndromes with bone marrow fibrosis.

    Kröger, N., Zabelina, T., van Biezen, A., Brand, R., Niederwieser, D., Martino, R., Lim, Z. Y., Onida, F., Schmid, C., Garderet, L., Robin, M., van Gelder, M., Marks, R., Symeonidis, A., Kobbe, G. & de Witte, T., 2011, In: HAEMATOLOGICA. 96, 2, p. 291-297 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  20. Approaches to relapse after allogeneic stem cell transplantation.

    Kröger, N., 2011, In: CURR OPIN ONCOL. 23, 2, p. 203-208 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  21. Assessment of physiologic natural killer cell cytotoxicity in vitro.

    Duske, H., Sputtek, A., Binder, T., Kröger, N., Schrepfer, S. & Eiermann, T., 2011, In: HUM IMMUNOL. 72, 11, p. 1007-1012 11.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  22. Bioequivalence comparison of a new freezing bag (CryoMACS(®)) with the Cryocyte(®) freezing bag for cryogenic storage of human hematopoietic progenitor cells.

    Sputtek, A., Lioznov, M., Kröger, N. & Rowe, A. W., 2011, In: CYTOTHERAPY. 13, 4, p. 481-489 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  23. Cancer-testis antigen expression and its epigenetic modulation in acute myeloid leukemia.

    Atanackovic, D., Luetkens, T., Kloth, B., Fuchs, G., Cao, Y., Hildebrandt, Y., Meyer, S., Bartels, K., Reinhard, H., Lajmi, N., Hegewisch-Becker, S., Schilling, G., Platzbecker, U., Kobbe, G., Schroeder, T., Bokemeyer, C. & Kröger, N., 2011, In: AM J HEMATOL. 86, 11, p. 918-922 11.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  24. Caspofungin plus posaconazole as salvage therapy of invasive fungal infections in immunocompromised patients.

    Lellek, H., Waldenmaier, D., Dahlke, J., Ayuketang Ayuk, F., Wolschke, C., Kröger, N. & Zander, A. R., 2011, In: MYCOSES. 54, 1, p. 39-44 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  25. Challenges for allogeneic hematopoietic stem cell transplantation in chronic myeloid leukemia in the era of tyrosine kinase inhibitors.

    Oyekunle, A., Klyuchnikov, E., Ocheni, S., Kröger, N., Zander, A. R., Baccarani, M. & Bacher, U., 2011, In: ACTA HAEMATOL-BASEL. 126, 1, p. 30-39 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  26. Circulating CD34(+) cells as prognostic and follow-up marker in patients with myelofibrosis undergoing allo-SCT.

    Alchalby, H., Lioznov, M., Fritzsche-Friedland, U., Badbaran, A., Zabelina, T., Bacher, U., Stübig, T., Ayuketang Ayuk, F., Zander, A. R. & Kröger, N., 2011, In: BONE MARROW TRANSPL. 47, 1, p. 143-145 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  27. Donor KIR haplotype B improves progression-free and overall survival after allogeneic hematopoietic stem cell transplantation for multiple myeloma.

    Kröger, N., Zabelina, T., Berger, J., Duske, H., Klyuchnikov, E., Binder, T., Stübig, T., Hildebrandt, Y., Atanackovic, D., Alchalby, H., Ayuketang Ayuk, F., Zander, A. R., Bacher, U. & Eiermann, T., 2011, In: LEUKEMIA. 25, 10, p. 1657-1661 10.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  28. Drug dosing and monitoring in obese patients undergoing allogenic stem cell transplantation.

    Langebrake, C., Bernhardt, F., Baehr, M., Kröger, N. & Zander, A. R., 2011, In: INT J CLIN PHARM-NET. 33, 6, p. 918-924 6.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  29. First-line matched related donor hematopoietic stem cell transplantation compared to immunosuppressive therapy in acquired severe aplastic anemia.

    Peinemann, F., Grouven, U., Kröger, N., Bartel, C., Pittler, M. H. & Lange, S., 2011, In: PLOS ONE. 6, 4, p. 18572 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  30. High-dose chemotherapy followed by autologous stem cell transplantation for metastatic rhabdomyosarcoma--a systematic review.

    Peinemann, F., Kröger, N., Bartel, C., Grouven, U., Pittler, M., Erttmann, R. & Kulig, M., 2011, In: PLOS ONE. 6, 2, p. 17127 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  31. International Myeloma Working Group consensus approach to the treatment of multiple myeloma patients who are candidates for autologous stem cell transplantation.

    Cavo, M., Rajkumar, S. V., Palumbo, A., Moreau, P., Orlowski, R., Bladé, J., Sezer, O., Ludwig, H., Dimopoulos, M. A., Attal, M., Sonneveld, P., Boccadoro, M., Anderson, K. C., Richardson, P. G., Bensinger, W., Johnsen, H. E., Kröger, N., Gahrton, G., Bergsagel, P. L., Vesole, D. H., Einsele, H., Jagannath, S., Niesvizky, R., Durie, B. G. M., Jesus, S. M., Lonial, S. & Group, I. M. W., 2011, In: BLOOD. 117, 23, p. 6063-6073 23.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  32. Minimal residual disease diagnostics and chimerism in the post-transplant period in acute myeloid leukemia.

    Bacher, U., Haferlach, T., Fehse, B., Schnittger, S. & Kröger, N., 2011, In: SCI WORLD J. 11, p. 310-319

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  33. Minimal residual disease following allogeneic hematopoietic stem cell transplantation.

    Kröger, N., Miyamura, K. & Bishop, M. R., 2011, In: BIOL BLOOD MARROW TR. 17, 1, p. 94-100 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  34. Molecular diagnostics, targeted therapy, and the indication for allogeneic stem cell transplantation in acute lymphoblastic leukemia.

    Oyekunle, A., Haferlach, T., Kröger, N., Klyuchnikov, E., Zander, A. R., Schnittger, S. & Bacher, U., 2011, In: Adv Hematol. 2011, p. 154745

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  35. National Cancer Institute's First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: summary and recommendations from the organizing committee.

    Bishop, M. R., Alyea, E. P., Cairo, M. S., Falkenburg, J. H. F., June, C. H., Kröger, N., Little, R. F., Miller, J. S., Pavletic, S. Z., Porter, D. L., Riddell, S. R., van Besien, K., Wayne, A. S., Weisdorf, D. J., Wu, R. S. & Giralt, S., 2011, In: BIOL BLOOD MARROW TR. 17, 4, p. 443-454 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  36. Patients with multiple myeloma develop SOX2-specific autoantibodies after allogeneic stem cell transplantation.

    Kobold, S., Tams, S., Luetkens, T., Cao, Y., Sezer, O., Bartels, B. M., Reinhard, H., Templin, J., Bartels, K., Hildebrandt, Y., Lajmi, N., Marx, A., Haag, F., Bokemeyer, C., Kröger, N. & Atanackovic, D., 2011, In: Clin Dev Immunol. 2011, p. 302145

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  37. Philadelphia-negative classical myeloproliferative neoplasms: critical concepts and management recommendations from European LeukemiaNet.

    Barbui, T., Barosi, G., Birgegard, G., Cervantes, F., Finazzi, G., Griesshammer, M., Harrison, C., Hasselbalch, H. C., Hehlmann, R., Hoffman, R., Kiladjian, J-J., Kröger, N., Mesa, R., McMullin, M. F., Pardanani, A., Passamonti, F., Vannucchi, A. M., Reiter, A., Silver, R. T., Verstovsek, S., Tefferi, A. & LeukemiaNet, E., 2011, In: J CLIN ONCOL. 29, 6, p. 761-770 6.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  38. Plerixafor with and without chemotherapy in poor mobilizers: results from the German compassionate use program.

    Hübel, K., Fresen, M. M., Salwender, H., Basara, N., Beier, R., Theurich, S., Christopeit, M., Bogner, C., Galm, O., Hartwig, R., Heits, F., Lordick, F., Rösler, W., Wehler, D., Zander, A. R., Albert, M. H., Dressler, S., Ebinger, M., Frickhofen, N., Hertenstein, B., Kiehl, M., Liebler, S., von Lilienfeld-Toal, M., Weidmann, E., Weigelt, C., Lange, F. & Kröger, N., 2011, In: BONE MARROW TRANSPL. 46, 8, p. 1045-1052 8.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  39. Recent advances in diagnosis, molecular pathology and therapy of chronic myelomonocytic leukaemia.

    Bacher, U., Haferlach, T., Schnittger, S., Kreipe, H. & Kröger, N., 2011, In: BRIT J HAEMATOL. 153, 2, p. 149-167 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  40. Surface molecule CD229 as a novel target for the diagnosis and treatment of multiple myeloma.

    Atanackovic, D., Panse, J., Hildebrandt, Y., Jadczak, A., Kobold, S., Cao, Y., Templin, J., Meyer, S., Reinhard, H., Bartels, K., Lajmi, N., Zander, A. R., Marx, A., Bokemeyer, C. & Kröger, N., 2011, In: HAEMATOLOGICA. 96, 10, p. 1512-1520 10.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  41. The Role of Allogeneic Stem Cell Transplantation in Relapsed/Refractory Hodgkin's Lymphoma Patients.

    Klyuchnikov, E., Bacher, U., Kröger, N., Kazantsev, I., Zabelina, T., Ayuketang Ayuk, F. & Zander, A. R., 2011, In: ANN HEMATOL. 2011, p. 974658

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  42. Thrombospondin-1 (TSP-1) in primary myelofibrosis (PMF) - a megakaryocyte-derived biomarker which largely discriminates PMF from essential thrombocythemia.

    Muth, M., Engelhardt, B. M., Kröger, N., Hussein, K., Schlué, J., Büsche, G., Kreipe, H. H. & Bock, O., 2011, In: ANN HEMATOL. 90, 1, p. 33-40 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  43. Unrelated cord blood transplantation in adults with myelodysplasia or secondary acute myeloblastic leukemia: a survey on behalf of Eurocord and CLWP of EBMT.

    Robin, M., Sanz, G. F., Ionescu, I., Rio, B., Sirvent, A., Renaud, M., Carreras, E., Milpied, N., Mohty, M., Beguin, Y., Bordigoni, P., de Witte, T., Picardi, A., Purtill, D., Gluckman, E., Kröger, N. & Rocha, V., 2011, In: LEUKEMIA. 25, 1, p. 75-81 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  44. Unusual course of myelodysplastic syndrome with presumed familial origin.

    Bacher, U., Ocheni, S., Schafhausen, P., Oyekunle, A., Dierlamm, J., Zander, A. R., Bokemeyer, C., Haferlach, T. & Kröger, N., 2011, In: ACTA HAEMATOL-BASEL. 126, 4, p. 234-237 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  45. 2010
  46. NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation.

    Porter, D. L., Alyea, E. P., Antin, J. H., DeLima, M., Estey, E., Falkenburg, J. H. F., Hardy, N., Kröger, N., Leis, J., Levine, J., Maloney, D. G., Peggs, K., Rowe, J. M., Wayne, A. S., Giralt, S., Bishop, M. R. & van Besien, K., 01.11.2010, In: BIOL BLOOD MARROW TR. 16, 11, p. 1467-1503 37 p., 11.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  47. Minimal residual disease diagnostics in patients with acute myeloid leukemia in the post-transplant period: comparison of peripheral blood and bone marrow analysis.

    Stahl, T., Badbaran, A., Kröger, N., Klyuchnikov, E., Zabelina, T., Zeschke, S., Schafhausen, P., Schultz, W., Asenova, S., Smirnova, A., Wolschke, C., Ayuketang Ayuk, F., Zander, A. R., Fehse, B. & Bacher, U., 01.10.2010, In: LEUKEMIA LYMPHOMA. 51, 10, p. 1837-1843 7 p., 10.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  48. Influence of mannose-binding lectin genotypes and serostatus in allo-SCT: analysis of 131 recipients and donors.

    Neth, O. W., Bacher, U., Das, P., Zabelina, T., Kabisch, H., Kroeger, N., Ayuketang, F. A., Lioznov, M., Waschke, O., Fehse, B., Thiébaut, R., Haston, R. M., Klein, N. & Zander, A. R., 01.01.2010, In: BONE MARROW TRANSPL. 45, 1, p. 13-9 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  49. Allogeneic hematopoietic stem-cell transplantation for patients 50 years or older with myelodysplastic syndromes or secondary acute myeloid leukemia.

    Lim, Z., Brand, R., Martino, R., van Biezen, A., Finke, J., Bacigalupo, A., Beelen, D., Devergie, A., Alessandrino, E., Willemze, R., Ruutu, T., Boogaerts, M., Falda, M., Jouet, J-P., Niederwieser, D., Kröger, N., Mufti, G. J., Witte, D. & Theo, M., 2010, In: J CLIN ONCOL. 28, 3, p. 405-411 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  50. Allogeneic hematopoietic stem-cell transplantation in patients with hematologic malignancies after dose-escalated treosulfan/fludarabine conditioning.

    Casper, J., Wolff, D., Knauf, W., Blau, I. W., Ruutu, T., Volin, L., Wandt, H., Schäfer-Eckart, K., Holowiecki, J., Giebel, S., Aschan, J., Zander, A. R., Kröger, N., Hilgendorf, I., Baumgart, J., Mylius, H. A., Pichlmeier, U. & Freund, M., 2010, In: J CLIN ONCOL. 28, 20, p. 3344-3351 20.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  51. Allogenic hematopoietic stem-cell transplantation with reduced-intensity conditioning in patients with refractory and recurrent multiple myeloma: long-term follow-up.

    Shimoni, A., Hardan, I., Ayuketang Ayuk, F., Schilling, G., Atanackovic, D., Zeller, W., Yerushalmi, R., Zander, A. R., Kröger, N. & Nagler, A., 2010, In: CANCER-AM CANCER SOC. 116, 15, p. 3621-3630 15.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  52. An optimized assay for the enumeration of antigen-specific memory B cells in different compartments of the human body.

    Cao, Y., Gordic, M., Kobold, S., Lajmi, N., Meyer, S., Bartels, K., Hildebrandt, Y., Luetkens, T., Ihloff, A-S., Kröger, N., Bokemeyer, C. & Atanackovic, D., 2010, In: J IMMUNOL METHODS. 358, 1-2, p. 56-65 1-2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  53. Chimerism studies with quantitative real-time PCR in stem cell recipients with acute myeloid leukemia.

    Wiedemann, B., Klyuchnikov, E., Kröger, N., Zabelina, T., Stahl, T., Zeschke, S., Badbaran, A., Ayuketang Ayuk, F., Alchalby, H., Wolschke, C., Bokemeyer, C., Fehse, B., Zander, A. R. & Bacher, U., 2010, In: EXP HEMATOL. 38, 12, p. 1261-1271 12.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review